Author

Marco Romano

SEXUAL DYSFUNCTION IN PATIENTS WITH GASTROENTEROLOGICAL DISORDERS: DO GASTROENTEROLOGISTS CARE ENOUGH?
SEXUAL DYSFUNCTION IN PATIENTS WITH GASTROENTEROLOGICAL DISORDERS: DO GASTROENTEROLOGISTS CARE ENOUGH?

BNT162B2 MRNA COVID-19 VACCINE SAFETY IN INFLAMMATORY BOWEL DISEASE PATIENTS ON BIOLOGIC THERAPY: A MONOCENTRIC REAL-WORLD STUDY
BNT162B2 MRNA COVID-19 VACCINE SAFETY IN INFLAMMATORY BOWEL DISEASE PATIENTS ON BIOLOGIC THERAPY: A MONOCENTRIC REAL-WORLD STUDY

Marco Romano  et al.

INFLUENCE OF DIABETES MELLITUS ON INFLAMMATORY BOWEL DISEASE COURSE AND TREATMENT OUTCOMES.A SYSTEMATIC REVIEW WITH META-ANALYSIS
INFLUENCE OF DIABETES MELLITUS ON INFLAMMATORY BOWEL DISEASE COURSE AND TREATMENT OUTCOMES.A SYSTEMATIC REVIEW WITH META-ANALYSIS

Marco Romano  et al.

ANTI-INFLAMMATORY EFFECTS OF HERICIUM ERINACEUS, BERBERINE, QUERCETIN, BIOTIN, AND NIACIN (HBQ-COMPLEX®) IN CROHN’S DISEASE AND ULCERATIVE COLITIS: AN EX VIVO TISSUE MODEL STUDY
ANTI-INFLAMMATORY EFFECTS OF HERICIUM ERINACEUS, BERBERINE, QUERCETIN, BIOTIN, AND NIACIN (HBQ-COMPLEX®) IN CROHN’S DISEASE AND ULCERATIVE COLITIS: AN EX VIVO TISSUE MODEL STUDY

Marco Romano  et al.

SEXUAL DYSFUNCTION IN PATIENTS WITH GASTROENTEROLOGICAL DISORDERS: DO GASTROENTEROLOGISTS CARE ENOUGH?
SEXUAL DYSFUNCTION IN PATIENTS WITH GASTROENTEROLOGICAL DISORDERS: DO GASTROENTEROLOGISTS CARE ENOUGH?

Marco Romano  et al.

REAL-LIFE EVALUATION OF GOLIMUMAB EFFECTIVENESS AND QUALITY OF LIFE IN PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE COLITIS: THE PROSPECTIVE GO-CARE STUDY
REAL-LIFE EVALUATION OF GOLIMUMAB EFFECTIVENESS AND QUALITY OF LIFE IN PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE COLITIS: THE PROSPECTIVE GO-CARE STUDY

Marco Romano  et al.

THE BURDEN OF URINARY SYMPTOMS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES: A CROSS-SECTIONAL OBSERVATIONAL STUDY
THE BURDEN OF URINARY SYMPTOMS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES: A CROSS-SECTIONAL OBSERVATIONAL STUDY

Marco Romano  et al.

EXPERIENCE WITH SINGLE CAPSULE BISMUTH QUADRUPLE THERAPY IN 5,000 PATIENTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
EXPERIENCE WITH SINGLE CAPSULE BISMUTH QUADRUPLE THERAPY IN 5,000 PATIENTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Marco Romano  et al.

EMPIRICAL FIRST-LINE TREATMENT USE AND EFFECTIVENESS TRENDS IN EUROPE IN THE PERIOD 2013-2020: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
EMPIRICAL FIRST-LINE TREATMENT USE AND EFFECTIVENESS TRENDS IN EUROPE IN THE PERIOD 2013-2020: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Marco Romano  et al.

EXPERIENCE WITH SINGLE-CAPSULE BISMUTH QUADRUPLE THERAPY IN 6,000 PATIENTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
EXPERIENCE WITH SINGLE-CAPSULE BISMUTH QUADRUPLE THERAPY IN 6,000 PATIENTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Marco Romano  et al.

EXPERIENCE WITH SINGLE-CAPSULE BISMUTH QUADRUPLE THERAPY IN 8,000 PATIENTS FROM THE EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG)
EXPERIENCE WITH SINGLE-CAPSULE BISMUTH QUADRUPLE THERAPY IN 8,000 PATIENTS FROM THE EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG)

Marco Romano  et al.

ROLE OF PROTON PUMP INHIBITORS DOSAGE IN THE EFFECTIVENESS OF HELICOBACTER PYLORI ERADICATION TREATMENTS: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
ROLE OF PROTON PUMP INHIBITORS DOSAGE IN THE EFFECTIVENESS OF HELICOBACTER PYLORI ERADICATION TREATMENTS: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Marco Romano  et al.

ERRORS IN EMPIRICAL ANTIBIOTIC THERAPIES FOR HELICOBACTER PYLORI ERADICATION IN 45,778 PATIENTS: DATA FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
ERRORS IN EMPIRICAL ANTIBIOTIC THERAPIES FOR HELICOBACTER PYLORI ERADICATION IN 45,778 PATIENTS: DATA FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Marco Romano  et al.

Item 1 - 13 / 13
1